Paper Details

  1. Home
  2. Paper Details

Overview of clinical safety and efficacy of tertatolol.

Author: VivetP

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Tertalolol, a beta-blocker, effectively lowers blood pressure and improves heart rate at submaximal exercise. It is safe and effective, with only 6.6% of patients experiencing side effects after 1 year of treatment.
Paper Details　
Original Abstract of the Article :
Tertalolol is a noncardioselective beta-blocker, devoid of intrinsic sympathomimetic activity. Its renal vasodilating properties have been demonstrated both in animals and in man. The beta-blocking activity of tertatolol was assessed on the reduction of heart rate at submaximal exercise. The oral do...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1159/000176009

データ提供：米国国立医学図書館（NLM）

Tertatolol: A Beta-Blocker Oasis in the Desert of Hypertension

Hypertension, a common condition characterized by high blood pressure, is a serious health concern, often leaving individuals seeking relief. This research explores the effectiveness and safety of tertatolol, a noncardioselective beta-blocker, in treating hypertension. The study investigates the effects of tertatolol on heart rate, blood pressure, and overall clinical safety, aiming to establish its potential as a safe and effective treatment option.

Finding Balance: Tertatolol and Hypertension

This research demonstrates the potential of tertatolol as a safe and effective treatment for hypertension. The study found that tertatolol effectively reduced heart rate and blood pressure, offering relief for individuals struggling with this common condition. The researchers also found that tertatolol was well-tolerated, with minimal side effects, highlighting its potential as a safe and effective treatment option.

A Journey Through the Desert: Navigating Hypertension Treatment

This research offers valuable insights into the treatment of hypertension, providing a better understanding of the potential benefits and risks associated with tertatolol. The findings suggest that tertatolol can be an effective and safe treatment option, offering relief for those suffering from high blood pressure. This research encourages clinicians to consider tertatolol as a viable option for managing hypertension, much like a camel traversing a desert might seek a reliable oasis.

Dr.Camel's Conclusion

This research offers a glimmer of hope in the desert of hypertension, demonstrating the potential of tertatolol as a safe and effective treatment option. It highlights the importance of understanding the nuances of different medications and their potential effects on the body, much like a camel navigating a desert must be aware of the terrain and its potential hazards. This research is a reminder that even in the most challenging landscapes, there is always the possibility of finding a better way forward.

Date :
  1. Date Completed 1994-01-25
  2. Date Revised 2018-02-15
Further Info :

Pubmed ID

7903214

DOI: Digital Object Identifier

10.1159/000176009

Related Literature

Article Analysis
・Side Effects of acebutolol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.